The landscape of metabolic disease management continues to undergo a profound transformation as clinical investigators unveil nuanced data regarding next-generation…
Read More
Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
